
The site is temporarily down due to maintenance. Sorry for the inconvenience.
The site is temporarily down due to maintenance. Sorry for the inconvenience.
Quality & Accuracy
Experience
The latest technologies
Speed &
Credibility
₾20.00 Original price was: ₾20.00.₾18.00Current price is: ₾18.00.
Coagulation is a process that takes place in the body to prevent excessive bleeding. However, the circulating blood in your blood vessels should not normally clot. If a blood clot forms and clots can form, a blood clot can travel through your bloodstream to your heart, lungs, or brain, causing a heart attack, stroke, or even death.
Coagulation tests determine the ability of a blood to clot and the time it takes to clot. Testing will help your doctor assess the risk of developing excessive bleeding or thrombosis.
The test is recommended in conjunction with other tests included in coagulation profiles
The examination is prescribed by a doctor.
The extension of aPTT is related to:
The reduction in aPTT is related to:
Prolonged aPTT indicates hemorrhagic disease, while reduced aPTT has been found to be an independent predictor of death at high risk of thrombosis and bleeding.
aPTT depends on the age of the patient: in infants the upper limit of aPTT extends to 55 s and gradually decreases to the adult level by 6 months; Prolonged values of aPTT in healthy children are caused by a mild deficiency of several coagulation proteins. Even in the elderly aPTT may be reduced.
Activated partial thromboplastin time (aPTT) The study is a functional test that provides important information about the functioning of the coagulation system and certain factors.
This indicator is most commonly used to control and monitor therapy with non-fractional heparin and thrombin inhibitors (hirudin, argatroban). However, aPTT is not a first-line indicator when evaluating heparin treatment.
The test is also used to diagnose congenital or acquired insufficiency of certain coagulation factors (XII, XI, IX, VIII, VII) in case of suspected hemophilia or von Willebrand disease.
The aPTT test is used to detect the presence of specific or nonspecific coagulation inhibitors in the body - for example, lupus anticoagulant and antiphospholipid antibodies that are associated with clinical manifestations such as thrombosis.
It is also used as an indicator to assess the risk of bleeding before surgery.
Blood sampling for analysis is necessary without fasting, without taking medication for the last 12 hours. The patient should be informed whether he or she is taking medications that affect blood clotting.
If you are taking blood thinners, consult your doctor about your examination.
If heparin therapy is required to be monitored, test material should be obtained from a non-heparinized source one hour prior to the next heparin administration.
Other tests




Testing process
|
Purchase a test |
Submission of material |
|
Results Online |
Consult a doctor |